These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25309923)

  • 1. Therapeutic use of microRNAs in lung cancer.
    Fortunato O; Boeri M; Verri C; Moro M; Sozzi G
    Biomed Res Int; 2014; 2014():756975. PubMed ID: 25309923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.
    Zarredar H; Ansarin K; Baradaran B; Shekari N; Eyvazi S; Safari F; Farajnia S
    Anticancer Agents Med Chem; 2018; 18(14):1991-2005. PubMed ID: 30088452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
    Ortholan C; Puissegur MP; Ilie M; Barbry P; Mari B; Hofman P
    Curr Med Chem; 2009; 16(9):1047-61. PubMed ID: 19275611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy.
    Wang QZ; Xu W; Habib N; Xu R
    Curr Cancer Drug Targets; 2009 Jun; 9(4):572-94. PubMed ID: 19519323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.
    Zhao Q; Li P; Ma J; Yu X
    Recent Pat Anticancer Drug Discov; 2015; 10(2):182-200. PubMed ID: 25600282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
    Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
    Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and Potential Targets in Osteosarcoma: Review.
    Sampson VB; Yoo S; Kumar A; Vetter NS; Kolb EA
    Front Pediatr; 2015; 3():69. PubMed ID: 26380245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
    Hung CH; Chiu YC; Chen CH; Hu TH
    Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNAs in lung cancer progression.
    Zhang WC; Liu J; Xu X; Wang G
    Med Oncol; 2013; 30(3):675. PubMed ID: 23925663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Dysregulated MicroRNA Expression in Lung Cancer.
    Krutakova M; Sarlinova M; Matakova T; Dzian A; Hamzik J; Pec M; Javorkova S; Halasova E
    Adv Exp Med Biol; 2016; 911():1-8. PubMed ID: 26987328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.
    Zhang C; Wang H; Liu X; Hu Y; Ding L; Zhang X; Sun Q; Li Y
    Oncogene; 2019 Mar; 38(11):1892-1904. PubMed ID: 30390072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review).
    Jiang YW; Chen LA
    Mol Med Rep; 2012 Apr; 5(4):890-4. PubMed ID: 22307769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis.
    Okudela K; Suzuki T; Umeda S; Tateishi Y; Mitsui H; Miyagi Y; Ohashi K
    Oncol Rep; 2014 Oct; 32(4):1374-84. PubMed ID: 25050641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
    Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Exosomal Noncoding RNAs in Lung Carcinogenesis.
    Sun T; Kalionis B; Lv G; Xia S; Gao W
    Biomed Res Int; 2015; 2015():125807. PubMed ID: 26583084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.